Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Research Report 2022

Publisher Name :
Date: 20-Sep-2022
No. of pages: 89
Inquire Before Buying

This report aims to provide a comprehensive presentation of the global market for Acute Myeloid Leukemia (AML) Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Myeloid Leukemia (AML) Biomarker Testing.

The Acute Myeloid Leukemia (AML) Biomarker Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Acute Myeloid Leukemia (AML) Biomarker Testing market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acute Myeloid Leukemia (AML) Biomarker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Abbott Laboratories

- Novartis AG

- Thermo Fisher Scientific

- Cancer Genetics Inc.

- Sysmex Corporation

- Epigenomics AG

- BioMerieux SA

- Skyline DX B.V.

Product Type Insights

Global markets are presented by Acute Myeloid Leukemia (AML) Biomarker Testing type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Acute Myeloid Leukemia (AML) Biomarker Testing are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Acute Myeloid Leukemia (AML) Biomarker Testing segment by Type

- Genetic Acute Myeloid Leukemia (AML) Biomarker

- Epigenetic Acute Myeloid Leukemia (AML) Biomarker

- Proteomic Acute Myeloid Leukemia (AML) Biomarker

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Acute Myeloid Leukemia (AML) Biomarker Testing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Acute Myeloid Leukemia (AML) Biomarker Testing market.

Acute Myeloid Leukemia (AML) Biomarker Testing Segment by Application

- Hospitals

- Cancer diagnostic Centers

- Research Institutes

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Acute Myeloid Leukemia (AML) Biomarker Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Myeloid Leukemia (AML) Biomarker Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Acute Myeloid Leukemia (AML) Biomarker Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Acute Myeloid Leukemia (AML) Biomarker Testing industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Myeloid Leukemia (AML) Biomarker Testing.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Acute Myeloid Leukemia (AML) Biomarker Testing companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Genetic Acute Myeloid Leukemia (AML) Biomarker
1.2.3 Epigenetic Acute Myeloid Leukemia (AML) Biomarker
1.2.4 Proteomic Acute Myeloid Leukemia (AML) Biomarker
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Cancer diagnostic Centers
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Perspective (2017-2028)
2.2 Acute Myeloid Leukemia (AML) Biomarker Testing Growth Trends by Region
2.2.1 Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Acute Myeloid Leukemia (AML) Biomarker Testing Historic Market Size by Region (2017-2022)
2.2.3 Acute Myeloid Leukemia (AML) Biomarker Testing Forecasted Market Size by Region (2023-2028)
2.3 Acute Myeloid Leukemia (AML) Biomarker Testing Market Dynamics
2.3.1 Acute Myeloid Leukemia (AML) Biomarker Testing Industry Trends
2.3.2 Acute Myeloid Leukemia (AML) Biomarker Testing Market Drivers
2.3.3 Acute Myeloid Leukemia (AML) Biomarker Testing Market Challenges
2.3.4 Acute Myeloid Leukemia (AML) Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Myeloid Leukemia (AML) Biomarker Testing Players by Revenue
3.1.1 Global Top Acute Myeloid Leukemia (AML) Biomarker Testing Players by Revenue (2017-2022)
3.1.2 Global Acute Myeloid Leukemia (AML) Biomarker Testing Revenue Market Share by Players (2017-2022)
3.2 Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Myeloid Leukemia (AML) Biomarker Testing Revenue
3.4 Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Concentration Ratio
3.4.1 Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia (AML) Biomarker Testing Revenue in 2021
3.5 Acute Myeloid Leukemia (AML) Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Acute Myeloid Leukemia (AML) Biomarker Testing Product Solution and Service
3.7 Date of Enter into Acute Myeloid Leukemia (AML) Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Myeloid Leukemia (AML) Biomarker Testing Breakdown Data by Type
4.1 Global Acute Myeloid Leukemia (AML) Biomarker Testing Historic Market Size by Type (2017-2022)
4.2 Global Acute Myeloid Leukemia (AML) Biomarker Testing Forecasted Market Size by Type (2023-2028)
5 Acute Myeloid Leukemia (AML) Biomarker Testing Breakdown Data by Application
5.1 Global Acute Myeloid Leukemia (AML) Biomarker Testing Historic Market Size by Application (2017-2022)
5.2 Global Acute Myeloid Leukemia (AML) Biomarker Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size (2017-2028)
6.2 North America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2017-2022)
6.3 North America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Acute Myeloid Leukemia (AML) Biomarker Testing Market Size (2017-2028)
7.2 Europe Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2017-2022)
7.3 Europe Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Myeloid Leukemia (AML) Biomarker Testing Market Size (2017-2028)
8.2 Asia-Pacific Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size (2017-2028)
9.2 Latin America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2017-2022)
9.3 Latin America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Myeloid Leukemia (AML) Biomarker Testing Market Size (2017-2028)
10.2 Middle East & Africa Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Acute Myeloid Leukemia (AML) Biomarker Testing Introduction
11.1.4 Abbott Laboratories Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Acute Myeloid Leukemia (AML) Biomarker Testing Introduction
11.2.4 Novartis AG Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
11.2.5 Novartis AG Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Acute Myeloid Leukemia (AML) Biomarker Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Cancer Genetics Inc.
11.4.1 Cancer Genetics Inc. Company Detail
11.4.2 Cancer Genetics Inc. Business Overview
11.4.3 Cancer Genetics Inc. Acute Myeloid Leukemia (AML) Biomarker Testing Introduction
11.4.4 Cancer Genetics Inc. Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
11.4.5 Cancer Genetics Inc. Recent Development
11.5 Sysmex Corporation
11.5.1 Sysmex Corporation Company Detail
11.5.2 Sysmex Corporation Business Overview
11.5.3 Sysmex Corporation Acute Myeloid Leukemia (AML) Biomarker Testing Introduction
11.5.4 Sysmex Corporation Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
11.5.5 Sysmex Corporation Recent Development
11.6 Epigenomics AG
11.6.1 Epigenomics AG Company Detail
11.6.2 Epigenomics AG Business Overview
11.6.3 Epigenomics AG Acute Myeloid Leukemia (AML) Biomarker Testing Introduction
11.6.4 Epigenomics AG Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
11.6.5 Epigenomics AG Recent Development
11.7 BioMerieux SA
11.7.1 BioMerieux SA Company Detail
11.7.2 BioMerieux SA Business Overview
11.7.3 BioMerieux SA Acute Myeloid Leukemia (AML) Biomarker Testing Introduction
11.7.4 BioMerieux SA Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
11.7.5 BioMerieux SA Recent Development
11.8 Skyline DX B.V.
11.8.1 Skyline DX B.V. Company Detail
11.8.2 Skyline DX B.V. Business Overview
11.8.3 Skyline DX B.V. Acute Myeloid Leukemia (AML) Biomarker Testing Introduction
11.8.4 Skyline DX B.V. Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
11.8.5 Skyline DX B.V. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Genetic Acute Myeloid Leukemia (AML) Biomarker
Table 3. Key Players of Epigenetic Acute Myeloid Leukemia (AML) Biomarker
Table 4. Key Players of Proteomic Acute Myeloid Leukemia (AML) Biomarker
Table 5. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Region (2017-2022)
Table 9. Global Acute Myeloid Leukemia (AML) Biomarker Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Region (2023-2028)
Table 11. Acute Myeloid Leukemia (AML) Biomarker Testing Market Trends
Table 12. Acute Myeloid Leukemia (AML) Biomarker Testing Market Drivers
Table 13. Acute Myeloid Leukemia (AML) Biomarker Testing Market Challenges
Table 14. Acute Myeloid Leukemia (AML) Biomarker Testing Market Restraints
Table 15. Global Acute Myeloid Leukemia (AML) Biomarker Testing Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Players (2017-2022)
Table 17. Global Top Acute Myeloid Leukemia (AML) Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing as of 2021)
Table 18. Ranking of Global Top Acute Myeloid Leukemia (AML) Biomarker Testing Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Acute Myeloid Leukemia (AML) Biomarker Testing Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Myeloid Leukemia (AML) Biomarker Testing Product Solution and Service
Table 22. Date of Enter into Acute Myeloid Leukemia (AML) Biomarker Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Acute Myeloid Leukemia (AML) Biomarker Testing Revenue Market Share by Type (2017-2022)
Table 26. Global Acute Myeloid Leukemia (AML) Biomarker Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Acute Myeloid Leukemia (AML) Biomarker Testing Revenue Market Share by Type (2023-2028)
Table 28. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Acute Myeloid Leukemia (AML) Biomarker Testing Revenue Market Share by Application (2017-2022)
Table 30. Global Acute Myeloid Leukemia (AML) Biomarker Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Acute Myeloid Leukemia (AML) Biomarker Testing Revenue Market Share by Application (2023-2028)
Table 32. North America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Acute Myeloid Leukemia (AML) Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 42. Abbott Laboratories Company Detail
Table 43. Abbott Laboratories Business Overview
Table 44. Abbott Laboratories Acute Myeloid Leukemia (AML) Biomarker Testing Product
Table 45. Abbott Laboratories Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022) & (US$ Million)
Table 46. Abbott Laboratories Recent Development
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Acute Myeloid Leukemia (AML) Biomarker Testing Product
Table 50. Novartis AG Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Thermo Fisher Scientific Company Detail
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Acute Myeloid Leukemia (AML) Biomarker Testing Product
Table 55. Thermo Fisher Scientific Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Cancer Genetics Inc. Company Detail
Table 58. Cancer Genetics Inc. Business Overview
Table 59. Cancer Genetics Inc. Acute Myeloid Leukemia (AML) Biomarker Testing Product
Table 60. Cancer Genetics Inc. Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022) & (US$ Million)
Table 61. Cancer Genetics Inc. Recent Development
Table 62. Sysmex Corporation Company Detail
Table 63. Sysmex Corporation Business Overview
Table 64. Sysmex Corporation Acute Myeloid Leukemia (AML) Biomarker Testing Product
Table 65. Sysmex Corporation Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022) & (US$ Million)
Table 66. Sysmex Corporation Recent Development
Table 67. Epigenomics AG Company Detail
Table 68. Epigenomics AG Business Overview
Table 69. Epigenomics AG Acute Myeloid Leukemia (AML) Biomarker Testing Product
Table 70. Epigenomics AG Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022) & (US$ Million)
Table 71. Epigenomics AG Recent Development
Table 72. BioMerieux SA Company Detail
Table 73. BioMerieux SA Business Overview
Table 74. BioMerieux SA Acute Myeloid Leukemia (AML) Biomarker Testing Product
Table 75. BioMerieux SA Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022) & (US$ Million)
Table 76. BioMerieux SA Recent Development
Table 77. Skyline DX B.V. Company Detail
Table 78. Skyline DX B.V. Business Overview
Table 79. Skyline DX B.V. Acute Myeloid Leukemia (AML) Biomarker Testing Product
Table 80. Skyline DX B.V. Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022) & (US$ Million)
Table 81. Skyline DX B.V. Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Type: 2021 VS 2028
Figure 2. Genetic Acute Myeloid Leukemia (AML) Biomarker Features
Figure 3. Epigenetic Acute Myeloid Leukemia (AML) Biomarker Features
Figure 4. Proteomic Acute Myeloid Leukemia (AML) Biomarker Features
Figure 5. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Application in 2021 & 2028
Figure 6. Hospitals Case Studies
Figure 7. Cancer diagnostic Centers Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Acute Myeloid Leukemia (AML) Biomarker Testing Report Years Considered
Figure 11. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Region: 2021 VS 2028
Figure 14. Global Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Players in 2021
Figure 15. Global Top Acute Myeloid Leukemia (AML) Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia (AML) Biomarker Testing as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia (AML) Biomarker Testing Revenue in 2021
Figure 17. North America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Country (2017-2028)
Figure 19. United States Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Country (2017-2028)
Figure 23. Germany Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Region (2017-2028)
Figure 31. China Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Country (2017-2028)
Figure 39. Mexico Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Acute Myeloid Leukemia (AML) Biomarker Testing Market Share by Country (2017-2028)
Figure 43. Turkey Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Acute Myeloid Leukemia (AML) Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
Figure 46. Novartis AG Revenue Growth Rate in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
Figure 48. Cancer Genetics Inc. Revenue Growth Rate in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
Figure 49. Sysmex Corporation Revenue Growth Rate in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
Figure 50. Epigenomics AG Revenue Growth Rate in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
Figure 51. BioMerieux SA Revenue Growth Rate in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
Figure 52. Skyline DX B.V. Revenue Growth Rate in Acute Myeloid Leukemia (AML) Biomarker Testing Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
  • Global Clear Aligner Market: Analysis By Treatment Cases, By Procedure (Doctor-Directed, and Direct-to-Consumer), By Age Group (Adult and Teen), By End-User (Standalone, Group Practices, Hospitals, and Other End-User), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
    Published: 30-Sep-2022        Price: US 2450 Onwards        Pages: 190
    The global clear aligner market was valued at US$3.98 billion in 2021. The market value is expected to reach US$13.13 billion by 2027. Clear aligners are orthodontic devices that are transparent, plastic forms of dental braces used to adjust teeth. Clear aligners are a new alternative to traditional metal braces. They’re made of clear, thin plastic that goes over the teeth and gradually shifts them into place. The factors such as the growing patient population suffering from mal......
  • Global Neonatal (Preterm) Infant Care Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 108
    Neonatal (preterm) infant care forms a significant part of the pediatric healthcare market in the global as neonatal (preterm) births are one of the leading causes of infant mortality in the worldwide. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Neonatal (Preterm) Infant Care market is projected to reach US$ 3330.8 million by 2028 from an estimated US$ 2402 million in 2022, at a CAGR of 5.6% during 2023 and 2028.......
  • Global Neurorehabilitation Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 106
    Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Neurorehabilitation market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. China Neurorehabilitation market size was US$ million in 2021, while the US and Europe Neurorehabilitation were US$ million and US$ million, severally. The proportion of the US was % in 2021, while China and Europe were % and % respectiv......
  • Global Personal Emergency Response Systems (PERS) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 122
    Personal emergency response system (PERS) is designed to signal the presence of a hazard and the requirement of urgent attention for the older population as well as people with disabilities during an emergency. Medical personnel are dispatched by response associates to assist the affected people accordingly for further care. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Personal Emergency Response Systems (PERS) mark......
  • Global Nitric Oxide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 81
    Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Nitric Oxide market is projected t......
  • Global Lumpectomy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 118
    Women who've been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy). A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure,......
  • Global Medical Laser Marking Machine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 118
    Laser marking machine is a type of machine that use laser beam to make permanent marking in various surface materials. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Medical Laser Marking Machine market is projected to reach US$ 382.5 million by 2028 from an estimated US$ 218.3 million in 2022, at a CAGR of 9.8% during 2023 and 2028. The top 10 companies had a combined market share of 56% of the global total in......
  • Global Plastic Injection Molding for Medical Device Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 138
    Plastic injection molding is an extremely versatile method of mass production, and it has numerous benefits that make it an invaluable tool for creating working prototypes at scale. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Plastic Injection Molding for Medical Device market is projected to reach US$ 46780 million by 2028 from an estimated US$ 34910 million in 2022, at a CAGR of 5.0% during 2023 and 2028. ......
  • Global SPECT and SPECT-CT Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 101
    Using specialized detector crystals that emit light when hit by photons (radiation emanating from the body) we are able to plot their origin on a grid or matrix using intricate x- y- coordinate circuitry that ultimately allows us to reconstruct the physiological and pathological processes taking place in the body pictographically by coupling radioactive isotopes to specific drugs, chemicals and molecules and administering them. Highlights Considering the economic change due......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs